artemisinin has been researched along with Neoplasms in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (11.63) | 29.6817 |
| 2010's | 22 (51.16) | 24.3611 |
| 2020's | 16 (37.21) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Bai, L; Gong, J; Jin, Y; Peng, T; Shi, J; Tong, R; Wei, X; Zhou, Y | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Emami, SA; Taleghani, A; Tayarani-Najaran, Z | 1 |
| Guo, N; Hu, Y; Li, X; Wang, W; Yan, J; Yang, T | 1 |
| Ackermann, L; Belyakova, YY; Çapcı, A; Dheeraj, A; Herrmann, L; Hodek, J; Malhotra, SV; Radulov, PS; Struwe, J; Tailor, D; Terent'ev, AO; Tsogoeva, SB; Weber, J; Yaremenko, IA | 1 |
| Chen, M; Huang, D; Kappen, M; Lin, F; Liu, S; Lu, J; Lu, L; Lu, S; Luo, X; Wang, Y; Xiong, G; You, C; Yu, S; Yu, Y | 1 |
| Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X | 1 |
| Hou, G; Qian, J; Suo, A; Wang, J; Wang, T; Wang, Y; Xu, W | 1 |
| Deng, K; Huang, SW; Li, JM; Li, KH; Wang, CX; Wang, Q; Wu, M; Yu, H; Zhou, W | 1 |
| Zhang, B | 1 |
| Gao, F; Kong, F; Sun, Z; Xiao, J | 1 |
| He, Q; Li, Y; Liu, J; Yuan, X; Zhou, X | 1 |
| Bi, J; Lu, Z; Wan, X | 1 |
| Dilshad, E; Ismail, H; Kayani, WK; Khayam, AU; Kiani, BH; Mirza, B | 1 |
| He, Y; Li, Y; Liu, Q; Shen, S; Wang, J; Wong, YK; Yang, J; Zhang, J; Zhang, X; Zhong, T | 1 |
| Cai, N; Cheng, K; Liang, H; Wen, J; Xiong, Y; Zhang, W; Zhang, Y; Zhu, J | 1 |
| Li, D; Zhang, J; Zhao, X | 1 |
| He, Y; Kalesh, KA; Lin, Q; Shen, HM; Wang, J; Wong, WSF; Wong, YK; Xu, C | 1 |
| He, T; Yu, H; Yu, HQ; Yue, QX | 1 |
| Hao, Y; Hu, Y; Li, L; Niu, M; Wang, L; Yin, Y; Zhang, Y; Zhang, Z; Zhao, H; Zheng, C | 1 |
| Benthani, FA; Bian, ZX; Chen, GQ; Jiang, X; Liang, D; Wu, J | 1 |
| Efferth, T; Li, Y; Shang, D; Wang, Y | 1 |
| Tan, XJ; Yang, H | 1 |
| Ba, Q; Chu, R; Huang, C; Li, J; Wang, H; Yue, Q | 1 |
| Takatani-Nakase, T | 1 |
| Chen, J; Chen, QW; Guo, Z; Wang, HB; Zhang, WJ; Zhou, JJ | 1 |
| Chen, J; Chen, Q; Guo, Z; He, M; Liu, Z; Wang, H; Xu, P; Zhang, M; Zhang, W; Zhou, J | 1 |
| Ba, Q; Gu, Z; Guo, D; Liu, H; Wang, H; Xu, Y; Ye, D; Zhang, X; Zhou, Y | 1 |
| Çapcı Karagöz, A; Fröhlich, T; Reiter, C; Tsogoeva, SB | 1 |
| Kinghorn, AD; Ren, Y; Yu, J | 1 |
| Chen, Q; Chen, R; Guo, Z; Li, R; Liu, Z; Shi, R; Tian, J; Wang, D; Wang, H; Xia, G; Zhao, G; Zhou, J | 1 |
| Dhatwalia, SK; Dhawan, DK; Kumar, M | 1 |
| Huang, L; Ju, H; Luo, Y; Sun, X; Tian, J; Yu, BY | 1 |
| Efferth, T | 2 |
| Firestone, GL; Sundar, SN | 1 |
| Chan, WC; Dalgleish, AG; Gravett, AM; Haynes, RK; Krishna, S; Liu, WM; Wilson, NL | 1 |
| Liu, C; Meng, H; Ren, L; Xie, L; Zhai, X; Zhao, Y; Zhu, W | 1 |
| Kumar, N; Rawat, DS; Sharma, M | 1 |
| Payne, AG | 1 |
| Lai, H; Sasaki, T; Singh, NP | 1 |
| Hoang, BX; Levine, SA; Pham, P; Shaw, DG | 1 |
24 review(s) available for artemisinin and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Inhibitors of phosphodiesterase as cancer therapeutics.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neoplasms; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship | 2018 |
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
Artemisia: a promising plant for the treatment of cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisia; Cell Proliferation; Humans; Molecular Structure; Neoplasms; Neoplasms, Experimental; Plant Extracts; Plants, Medicinal | 2020 |
The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer.
Topics: Anti-Infective Agents; Artemisinins; Ferroptosis; Humans; Medicine, Chinese Traditional; Neoplasms; Plants | 2022 |
Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
Topics: Antineoplastic Agents; Artemisinins; Cell Proliferation; Dimerization; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2020 |
Artemisinin-derived hybrids and their anticancer activity.
Topics: Antineoplastic Agents; Artemisinins; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Neoplasms; Structure-Activity Relationship | 2020 |
Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Topics: Animals; Antineoplastic Agents; Artemisinins; Carcinogenesis; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Neoplasms | 2020 |
Artemisinin and its derivatives: a promising cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisia; Artemisinins; Cell Cycle; Cell Movement; Humans; Neoplasms | 2020 |
Advances in the research on the targets of anti-malaria actions of artemisinin.
Topics: Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Drug Repositioning; Host-Parasite Interactions; Humans; Malaria; Neoplasms; Plasmodium | 2020 |
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella | 2020 |
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Artemisinins; Humans; Molecular Targeted Therapy; Neoplasms | 2017 |
[Research progress on anti-cancer mechanisms of arsenic trioxide and artemisinin].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Artemisinins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasms; Oxides; Signal Transduction | 2016 |
Interactions between artemisinin derivatives and P-glycoprotein.
Topics: Antineoplastic Agents; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Neoplasms | 2019 |
[Research advance in antitumor activities of artemisinin and its derivatives].
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Humans; Neoplasms; Neovascularization, Pathologic | 2013 |
[Artemisinin: a natural product for fighting against cancer].
Topics: Antimalarials; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Biological Products; Drug Delivery Systems; Drug Design; Energy Metabolism; Humans; Neoplasms; Oxidative Stress; Phytotherapy; Transferrin | 2014 |
Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Artemisinins; Dimerization; Heterocyclic Compounds; Humans; Malaria; Molecular Conformation; Neoplasms | 2016 |
Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Humans; Lactones; Neoplasms; Plants, Medicinal; Sesquiterpenes; Structure-Activity Relationship | 2016 |
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes | 2016 |
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy.
Topics: Artemisia annua; Artemisinins; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neoplasms; Oxidative Stress | 2017 |
Anticancer activities of artemisinin and its bioactive derivatives.
Topics: Anti-Infective Agents; Apoptosis; Apoptosis Regulatory Proteins; Artemisia annua; Artemisinins; Cell Cycle; Cell Movement; Humans; Neoplasms; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Transferrin; Tumor Suppressor Protein p53 | 2009 |
Medicinal chemistry perspectives of trioxanes and tetraoxanes.
Topics: Animals; Antimalarials; Antineoplastic Agents; Artemisia; Artemisinins; Heterocyclic Compounds; Humans; Malaria; Neoplasms; Plasmodium; Tetraoxanes | 2011 |
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.
Topics: Antineoplastic Agents; Artemisinins; Drug Delivery Systems; Humans; Iron; Neoplasms; Sesquiterpenes | 2005 |
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Genes, Tumor Suppressor; Genetic Engineering; Humans; Neoplasms; Oxidative Stress; Pharmacogenetics; Sesquiterpenes; Tumor Protein, Translationally-Controlled 1 | 2006 |
19 other study(ies) available for artemisinin and Neoplasms
| Article | Year |
|---|---|
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and Cancer.
Topics: Animals; Antiviral Agents; Artemisinins; Chlorocebus aethiops; COVID-19 Drug Treatment; Humans; Leukemia; Neoplasms; Peroxides; Quinolines; SARS-CoV-2; Vero Cells | 2022 |
Near-Infrared-II Light Induced Mild Hyperthermia Activate Cisplatin-Artemisinin Nanoparticle for Enhanced Chemo/Chemodynamic Therapy and Immunotherapy.
Topics: Animals; Artemisinins; Artesunate; Cisplatin; Humans; Hyperthermia, Induced; Immunotherapy; Mice; Nanoparticles; Neoplasms; Prodrugs; Serum Albumin, Human; Tumor Microenvironment | 2022 |
Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; DNA Damage; Glutathione Peroxidase; Humans; Leukemia; Mechlorethamine; Neoplasms | 2022 |
Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy.
Topics: Apoptosis; Artemisinins; Cell Line, Tumor; Combined Modality Therapy; Copper; Neoplasms; Oxidative Stress; Tumor Microenvironment | 2023 |
GPX4 inhibition synergistically boosts mitochondria targeting nanoartemisinin-induced apoptosis/ferroptosis combination cancer therapy.
Topics: Apoptosis; Artemisinins; Ferroptosis; Mitochondria; Neoplasms; Oxygen | 2023 |
Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis.
Topics: Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cells, Cultured; Cytotoxicity, Immunologic; Humans; Immunologic Surveillance; Killer Cells, Natural; Mice; Neoplasms | 2020 |
Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment.
Topics: Antineoplastic Agents; Artemisinins; Humans; Neoplasms | 2021 |
Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Artemisinins; Delayed-Action Preparations; Drug Delivery Systems; Hep G2 Cells; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Levulinic Acids; Mice, Nude; Nanoparticles; Neoplasms; Polylactic Acid-Polyglycolic Acid Copolymer; Ultrasonic Therapy; Ultrasonic Waves | 2018 |
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.
Topics: Animals; Antineoplastic Agents; Artemisinins; Autophagy; Cell Line, Tumor; Female; Ferroptosis; Homeostasis; Humans; Iron; Iron-Regulatory Proteins; Lysosomes; Mice, Nude; Neoplasms; Response Elements | 2020 |
Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Computational Biology; Databases, Bibliographic; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Signal Transduction; Toll-Like Receptor 4 | 2013 |
Multifunctional mesoporous nanoparticles as pH-responsive Fe(2+) reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth.
Topics: Artemisinins; Cell Death; Cell Proliferation; Drug Carriers; Endocytosis; Ferric Compounds; HeLa Cells; Humans; Hydrogen-Ion Concentration; Iron; MCF-7 Cells; Nanoparticles; Neoplasms; Porosity; Silicon Dioxide; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2014 |
Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.
Topics: Animals; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Survival; Drug Carriers; Female; Ferrosoferric Oxide; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Magnetic Resonance Imaging; Manganese; Mice; Mice, Nude; Microscopy, Confocal; Nanospheres; Neoplasms; Radiography; Tissue Distribution; Transplantation, Heterologous | 2015 |
Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities.
Topics: Apoptosis; Artemisinins; Coumarins; Drug Delivery Systems; Fluorescent Dyes; Humans; Mitochondria; Neoplasms; Reactive Oxygen Species; Theranostic Nanomedicine | 2015 |
Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy.
Topics: Animals; Antineoplastic Agents; Artemisinins; Combined Modality Therapy; Delayed-Action Preparations; Female; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Magnetic Resonance Imaging; Mice, Inbred BALB C; Multimodal Imaging; Nanoparticles; Neoplasms; Optical Imaging; Organometallic Compounds; Phototherapy; Theranostic Nanomedicine | 2016 |
An artemisinin-mediated ROS evolving and dual protease light-up nanocapsule for real-time imaging of lysosomal tumor cell death.
Topics: Animals; Apoptosis; Artemisinins; Biosensing Techniques; Caspase 3; Cathepsin B; Cell Line, Tumor; HeLa Cells; Humans; Lysosomes; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Nanocapsules; Neoplasms; Optical Imaging; Permeability; Reactive Oxygen Species | 2017 |
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.
Topics: Antineoplastic Agents; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dose-Response Relationship, Drug; Flow Cytometry; Gemcitabine; Humans; Immunoblotting; Inhibitory Concentration 50; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Thalidomide | 2011 |
Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.
Topics: Antineoplastic Agents, Phytogenic; Artemisia; Artemisinins; Cell Line, Tumor; Chalcone; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neoplasms; Structure-Activity Relationship | 2011 |
Exploiting intracellular iron and iron-rich compounds to effect tumor cell lysis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Humans; Hyperthermia, Induced; Iron; Neoplasms; Receptors, Transferrin; Sesquiterpenes | 2003 |
Hypothesis of the cause and development of neoplasms.
Topics: Anti-Infective Agents; Anticonvulsants; Antineoplastic Agents; Artemisia; Artemisinins; Cell Death; Cell Membrane; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Mutation; Neoplasms; Pain, Intractable; Phenytoin; Sesquiterpenes; Sodium Channels | 2007 |